Encouraging Data From Edwards
Last week, Edwards Lifesciences (NYSE:EW) presented positive long-term data from Cohort A of the PARTNER Trial. The aim of the study was to evaluate patients considered to be at high risk for surgery who were treated with either surgical aortic valve replacement or the Sapien transcatheter heart valve (“THV”). Data from the study were published [...]
Last week, Edwards Lifesciences (NYSE:EW) presented positive long-term data from Cohort A of the PARTNER Trial. The aim of the study was to evaluate patients considered to be at high risk for surgery who were treated with either surgical aortic valve replacement or the Sapien transcatheter heart valve (“THV”). Data from the study were published in the New England Journal of Medicine and simultaneously presented at a conference in Chicago.
Cohort A of the PARTNER Trial studied 699 patients with … [visit site to read more] or compare Credit Card Rewards and Best Credit Cards